Tumor penetrating peptide-functionalized Tenascin-C antibody for glioblastoma targeting.
Sign Up to like & getrecommendations! Published in 2020 at "Current cancer drug targets"
DOI: 10.2174/1568009620666201001112749
Abstract: BACKGROUND Conjugation to clinical-grade tumor penetrating iRGD peptide is a widely used strategy to improve tumor homing, extravasation, and penetration of cancer drugs and tumor imaging agents. The C domain of extracellular matrix molecule Tenascin-C… read more here.
Keywords: irgd; antibody; tumor penetrating; scfv g11 ... See more keywords